Effects of a Liquid Meal and Gut Hormones (GIP and GLP-2) on Bone Remodeling in Participants With Hypoparathyroidism.
NCT03728959 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2019-12-12
Summary
Hypoparathyroidism (hypoPT) is characterized by low levels of PTH.
In this study we will test the effects of a liquid meal on the bone remodeling in participants with hypoparathyroidism. Furthermore, we will test the effects of the gut hormones GIP and GLP-2.
Conditions
- Hypoparathyroidism
Interventions
- OTHER
-
Liquid meal (Nutridrink)
Liquid meal ingested over 1 minute.
- OTHER
-
GIP
Subcutaneous injected GIP
- OTHER
-
GLP-2
Subcutaneous injected GLP-2
- OTHER
-
Placebo (saline)
Subcutaneous injected Placebo (saline)
Sponsors & Collaborators
-
Hvidovre University Hospital
collaborator OTHER -
University of Copenhagen
lead OTHER
Principal Investigators
-
Mette Rosenkilde, MD · University of Copenhagen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 76 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-09-12
- Primary Completion
- 2019-04-12
- Completion
- 2019-04-12
Countries
- Denmark
Study Locations
More Related Trials
-
Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
NCT04522622 ·Status: RECRUITING ·Phase: PHASE4
-
Parathyroid Allotransplant for Treatment of Hypoparathyroidism
NCT06961071 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Oral Peptones Load in Normocalcemic and Hypercalcemic Primary Hyperparathyroidism and Healthy Subjects
NCT01042626 ·Status: COMPLETED ·Phase: NA
-
Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism
NCT06859580 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)
NCT03324880 ·Status: COMPLETED ·Phase: PHASE4
-
One Week Comparison Study of PTH and PTHrP Infusions
NCT01333267 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
NCT02152228 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP
NCT06487143 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Treatment With Indapamide in Patients With Post-Surgical Hypoparathyroidism
NCT07034677 ·Status: RECRUITING ·Phase: PHASE4
-
Comparison Study of PTHrP and PTH to Treat Osteoporosis
NCT00853723 ·Status: COMPLETED ·Phase: PHASE2
-
Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced Osteoporosis
NCT00004993 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium Concentrations
NCT02204579 ·Status: COMPLETED ·Phase: PHASE2
-
ADD-ON Study to Existing Hypoparathyroidism Studies
NCT00856401 ·Status: UNKNOWN ·Phase: PHASE3
-
Glucocorticoids and Bone in Graves' Ophthalmopathy
NCT03122847 ·Status: COMPLETED
-
A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism
NCT04209179 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of a Ghrelin Receptor Agonist on Muscle and Bone
NCT04021706 ·Status: COMPLETED ·Phase: PHASE1
-
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
NCT01381926 ·Status: TERMINATED ·Phase: PHASE4
-
3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women
NCT00222872 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism
NCT02525796 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur
NCT01309399 ·Status: COMPLETED ·Phase: NA
-
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
NCT00221299 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of PTH(1-34) Treatment on Fracture Healing in Vivo
NCT00741182 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid
NCT02274623 ·Status: COMPLETED ·Phase: PHASE1
-
Calcium Supplementation in Postmenopausal Women
NCT00172172 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic Osteoporosis
NCT00004406 ·Status: COMPLETED ·Phase: NA